PROTEOMIC ANALYSIS OF CANCER PATIENT PLASMA SAMPLES
SAM.GOV Due: June 20, 2025 at 09:00 PM UTC
In-Active Combined Synopsis/Solicitation Source Url

Summary

The opportunity titled 'PROTEOMIC ANALYSIS OF CANCER PATIENT PLASMA SAMPLES' involves conducting a comprehensive analysis of plasma samples from cancer patients, specifically focusing on the quantitation of over 5000 proteins across 100 samples. The contractor will be responsible for delivering detailed reports that include study design, experimental conditions, and results in parquet file format. This work will be performed at the contractor's laboratory, and no installation or training is required. This is a one-time analysis, making it suitable for businesses with expertise in proteomics and laboratory analysis, particularly those familiar with handling biological samples and data reporting.
Description

Reports of the sample analysis and results of relative quantitation of over 5000 proteins for each of 100 human plasma samples will be delivered. Data provided shall in parquet files, including study design, experimental conditions, and results for each protein analyzed. This analysis will be con

Entities
HAHSDO
Department of Health and Human Services
FADA
Food and Drug Administration
NAICS
541720
Set Aside
None
Place of Performance
Jefferson , Arkansas 72079
Point of Contact
Full Name Email Phone Type
Ronald Paraham [email protected] primary
Attachments
  • FDA-RFQ-75F40125Q00169_LY.docx